Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Open accessThe DOI matches its Crossref record; 333 of the 335 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease after Alzheimer’s disease, globally. Dopaminergic neuron degeneration in substantia nigra pars compacta and aggregation of misfolded alpha-synuclein are the PD hallmarks, accompanied by motor and non-motor symptoms. Several viruses have been linked to the appearance of a post-infection parkinsonian phenotype. Coronavirus disease 2019 (COVID-19), caused by emerging severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, has evolved from a novel pneumonia to a multifaceted syndrome with multiple clinical manifestations, among which neurological sequalae appear insidious and potentially long-lasting. Exosomes are extracellular nanovesicles bearing a complex cargo of active biomolecules and playing crucial roles in intercellular communication under pathophysiological conditions. Exosomes constitute a reliable route for misfolded protein transmission, contributing to PD pathogenesis and diagnosis. Herein, we summarize recent evidence suggesting that SARS-CoV-2 infection shares numerous clinical manifestations and inflammatory and molecular pathways with PD. We carry on hypothesizing that these similarities may be reflected in exosomal cargo modulated by the virus in correlation with disease severity. Travelling from the periphery to the brain, SARS-CoV-2-related exosomal cargo contains SARS-CoV-2 RNA, viral proteins, inflammatory mediators, and modified host proteins that could operate as promoters of neurodegenerative and neuroinflammatory cascades, potentially leading to a future parkinsonism and PD development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, SARS-CoV-2 directly induces AD pathogenesis such as neuronal damage and amyloid processing,278–280 as well as PD pathogenesis including α-syn aggregation and dopaminergic neuronal loss in various models.281”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [281]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 2×
“They represent a recently discovered mode of intercellular communic tion that may play a major rol in many c llular processes in both physiological and pathological c ditions [217,218].”
BackgroundStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“structures [101,102] and they constitute principal areas of LB accumulation, even at the earliest stages of disease development [91].”
BackgroundThe biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926 · cited 15×
“Exosomes are EVs [219] with a cup-shaped appearance in transmission electron mi-”
BackgroundInfluentialParkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · cited 1×
“The incremental loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and striatum is the mechanistic cause of motor manifestations, with 60–70% dopaminergic neuron loss required for the appearance of motor symptoms [11].”
BackgroundExosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346 · cited 2×
“Exosomes, the nanosized vesicles and masters of intercellular communication [31], have been proposed to serve as an efficient “vehicle” of transportation for such proteins [32], mainly because they are a priori involved in several homeostatic procedures in the central nervous system (CNS) including myelination mainten…”
BackgroundTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405 · cited 1×
“Growing evidence suggests that SARS-CoV-2 proteins interact with the ER compartment and may induce ER stress [194,195].”
BackgroundWu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389 · cited 1×
“Due to its enhanced transmissibility, this unusual coronavirus disease, also known as coronavirus disease 2019 (COVID-19), marched fast over the world, constituting a huge public health burden [62,63].”
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Mathieu, M., Martin-Jaular, L., Lavieu, G., & Théry, C. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0250-9 · Cited by 3,737
Doyle, L., & Wang, M. (2019) · Cells · doi:10.3390/cells8070727 · Cited by 3,236
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233 · cited 7×
“Aside from initiating apoptotic pathways, ER stress is a powerful stimulator of NF-κB activation and inflammatory gene transcription [198,199].”
BackgroundInfluentialMechanisms of SARS-CoV-2 entry into cells
Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,022 · cited 1×
“In SARS-CoV-2 infection, the virus uses multiple steps to achieve entry into the host cell, including ACE2mediated receptor binding and transmembrane serine protease-2 (TMPRSS2)-mediated intracellular cleavage [287].”
BackgroundThe blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · cited 1×
“A neurovascular unit (NVU) consists of multiple cell types, including brain microvascular endothelial cells (BMVECs), astrocytes, pericytes, microglia, and neurons, connected together with extracellular matrix components, and is a rigorous regulator of BBB permeability [127].”
BackgroundMarciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., Nagata, K., Harding, H. P., & Ron, D. (2004) · Genes & Development · doi:10.1101/gad.1250704 · Cited by 2,001 · cited 1×
“ER homeostasis disruption and extended ER stress lead to misfolded protein accumulation and may stimulate particular proapoptotic pathways through the activation of the transcription factor C/EBP homologous protein (CHOP) and cysteine proteases caspase-4/12 [192,193].”
BackgroundA blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853 · cited 1×
“Functional and structural integrity of the BBB is pivotal in maintaining brain homeostasis [126].”
BackgroundThe Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
The exosome journey: from biogenesis to uptake and intracellular signalling
Gurung, S., Perocheau, D., Touramanidou, L., & Baruteau, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00730-1 · Cited by 1,791
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase
Russell, R. C., Tian, Y., Yuan, H., Park, H. W., Chang, Y.-Y., Kim, J., Kim, H., Neufeld, T. P., Dillin, A., & Guan, K.-L. (2013) · Nature Cell Biology · doi:10.1038/ncb2757 · Cited by 1,529 · cited 1×
“ULK1 is an upstream autophagy orchestrator, which phosphorylates key regulatory proteins in autophagosome formation [212].”
BackgroundThe central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513 · cited 1×
“This warrants further investigation because GI microbiota equilibrium plays an important role in several physiological processes ensuring brain integrity and neurogenesis [109,110].”
BackgroundInclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · cited 1×
“Other researchers used various in vitro and ex vivo cellular systems to verify the presence of α-syn in exosomes [243,244].”
BackgroundMeinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Brünink, S., Greuel, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00758-5 · Cited by 1,458 · cited 2×
“In this regard, the olfactory mucosa could serve as an “anatomical bridge” for SARS-CoV-2 CNS invasion through axonal transport [88].”
BackgroundKim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397 · cited 1×
“From there, α-syn can spread to other PD brain regions including the SNpc, resulting in dopaminergic neuron loss and the appearance of the parkinsonian phenotype [103].”
BackgroundExosomal-like vesicles are present in human blood plasma
Caby, M.-P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., & Bonnerot, C. (2005) · International Immunology · doi:10.1093/intimm/dxh267 · Cited by 1,343
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Matschke, J., Lütgehetmann, M., Hagel, C., Sperhake, J. P., Schröder, A. S., Edler, C., Mushumba, H., Fitzek, A., Allweiss, L., Dandri, M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30308-2 · Cited by 1,300 · cited 1×
“A postmortem brain study of 43 COVID-19 patients has shown activation of microglia and CNS infiltration by cytotoxic T-lymphocytes, more apparent in the brainstem [146].”
BackgroundOxidative stress and apoptosis
Kannan, K., & Jain, S. K. (2000) · Pathophysiology · doi:10.1016/s0928-4680(00)00053-5 · Cited by 1,284
Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study
Zaborowski, M. P., Balaj, L., Breakefield, X. O., & Lai, C. P. (2015) · BioScience · doi:10.1093/biosci/biv084 · Cited by 1,268 · cited 2×
“cles, exosomes, and apoptotic bodies) secreted by the cells [214].”
BackgroundBrann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., Van den Berge, K., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5801 · Cited by 1,198
Identification of Tim4 as a phosphatidylserine receptor
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., & Nagata, S. (2007) · Nature · doi:10.1038/nature06307 · Cited by 1,180
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · cited 1×
“The ensuing neuroinflammation and dopaminergic neuron loss in the SNpc could conceivably lead to a PD phenotype [308,309].”
BackgroundReactive oxygen species: from health to disease
Brieger, K., Schiavone, S., Miller Jr., F. J., & Krause, K.-H. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13659 · Cited by 1,133 · cited 4×
“Exosomes contain cell-specific cargos of proteins, lipids, DNAs, and coding/non-coding RNAs from the donor cells that can be preferentially de- livered to targeted recipient cells.”
BackgroundInfluentialThe emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., Jayaseelan, D. L., Kumar, G., Raftopoulos, R. E., Zambreanu, L., et al. (2020) · Brain · doi:10.1093/brain/awaa240 · Cited by 1,124
Exosomes: proteomic insights and diagnostic potential
Simpson, R. J., Lim, J. W., Moritz, R. L., & Mathivanan, S. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.17 · Cited by 1,108 · cited 2×
“They represent a recently discovered mode of intercellular communic tion that may play a major rol in many c llular processes in both physiological and pathological c ditions [217,218].”
BackgroundSARS-CoV-2 Transmission From People Without COVID-19 Symptoms
Johansson, M. A., Quandelacy, T. M., Kada, S., Prasad, P. V., Steele, M., Brooks, J. T., Slayton, R. B., Biggerstaff, M., & Butler, J. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.35057 · Cited by 1,025 · cited 1×
“SARS-CoV-2 spreads via infected secretions, such as saliva and respiratory droplets, through direct, indirect, or close contact with infected patients, even if COVID-19 symptomatology is absent [64,65].”
BackgroundTaquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003773 · Cited by 927
Exosomes: A Common Pathway for a Specialized Function
van Niel, G., Porto-Carreiro, I., Simoes, S., & Raposo, G. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj128 · Cited by 922 · cited 2×
“The ESCRT machinery consists of a set of cytosolic protein complexes that become attracted to endosomes by membrane proteins usually tagged with ubiquitin [226].”
BackgroundArizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911 · cited 1×
“structures [101,102] and they constitute principal areas of LB accumulation, even at the earliest stages of disease development [91].”
BackgroundExpanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869 · cited 1×
“A key molecular factor in PD development and progression is mitochondrial dysfunction and oxidative stress [171,172].”
BackgroundExosomal cell-to-cell transmission of alpha synuclein oligomers
Danzer, K. M., Kranich, L. R., Ruf, W. P., Cagsal-Getkin, O., Winslow, A. R., Zhu, L., Vanderburg, C. R., & McLean, P. J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-42 · Cited by 853 · cited 1×
“Danzer and colleagues identified the presence of oligomeric α-syn in exosomes from continuous cell lines and primary cells and demonstrated that exosomal α-syn is more easily taken up by recipient cells than the free oligomeric form of protein [242].”
BackgroundHansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842
Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death
Hitomi, J., Katayama, T., Eguchi, Y., Kudo, T., Taniguchi, M., Koyama, Y., Manabe, T., Yamagishi, S., Bando, Y., Imaizumi, K., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200310015 · Cited by 830 · cited 1×
“ER homeostasis disruption and extended ER stress lead to misfolded protein accumulation and may stimulate particular proapoptotic pathways through the activation of the transcription factor C/EBP homologous protein (CHOP) and cysteine proteases caspase-4/12 [192,193].”
BackgroundWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821 · cited 1×
“A sound inflammatory response is essential for tissue repair and misfolded protein breakdown, but an excessive and delayed inflammatory response can lead to a deregulated neuroinflammatory cycle [251].”
BackgroundBiogenesis and function of extracellular vesicles in cancer
Bebelman, M. P., Smit, M. J., Pegtel, D. M., & Baglio, S. R. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.013 · Cited by 811 · cited 2×
“Exosome emerge from the end omal compartment following a series of events, starting with the inward buddi g f the plas a me brane that ives ise to th early endosome [222].”
BackgroundObesity and neuroinflammation: A pathway to cognitive impairment
Miller, A. A., & Spencer, S. J. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.001 · Cited by 788
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 783 · cited 1×
“A key molecular factor in PD development and progression is mitochondrial dysfunction and oxidative stress [171,172].”
BackgroundAlpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
Rocha, E. M., De Miranda, B., & Sanders, L. H. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.004 · Cited by 762 · cited 1×
“At the same time, microglia could be activated by exosomal α-syn, and elicit an immunological response with the release of pro-inflammatory cytokines, resulting in dopaminergic neuron death [253].”
BackgroundLysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Gardiner, C., Sargent, I. L., Wood, M. J. A., & Cooper, J. M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.029 · Cited by 748 · cited 2×
“Specifically, when other cellular clearance systems, such as the proteasome and ALP, fail to eliminate aggregated amyloidogenic proteins, exosomes come to the rescue [237].”
BackgroundOlfactory dysfunction in Parkinson disease
Doty, R. L. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.80 · Cited by 737 · cited 1×
“Indeed, both olfactory and gustatory impairments are among the earliest non-motor PD features [84,85].”
BackgroundMultivesicular Endosome Biogenesis in the Absence of ESCRTs
Stuffers, S., Sem Wegner, C., Stenmark, H., & Brech, A. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00920.x · Cited by 729 · cited 2×
“This multi-subunit protein system is essential for membrane remodeling and cargo sorting of MVBs [227], although some studies found that ILVs are also formed in the absence of ESCRT machinery (ESCRT-independent pathway), with the enzyme sphingomyelinase and tetraspanin proteins, such as CD9, CD63, and CD81, playing a…”
BackgroundExosomes and other extracellular vesicles in host–pathogen interactions
Schorey, J. S., Cheng, Y., Singh, P. P., & Smith, V. L. (2015) · EMBO reports · doi:10.15252/embr.201439363 · Cited by 727 · cited 1×
“Exosomes released during viral infection contain inflammatory markers that cause a strong inflammatory response, acting as pathogen-related molecular patterns, thereby enhancing pathogenicity [290].”
BackgroundNasserie, T., Hittle, M., & Goodman, S. N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11417 · Cited by 702
Augustin, M., Schommers, P., Stecher, M., Dewald, F., Gieselmann, L., Gruell, H., Horn, C., Vanshylla, K., Cristanziano, V. D., Osebold, L., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100122 · Cited by 700 · cited 1×
“Surprisingly, these are common early onset symptoms of COVID-19 and it has been observed that hyposmia– anosmia and dysgeusia could persist long after viral load decline, constituting a key clinical manifestation of the long COVID-19 syndrome [86,87].”
BackgroundMartin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684
Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M.-P., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, E. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7531 · Cited by 678 · cited 1×
“Notably, NF-κB is a crucial transcription factor that regulates inflammation and dopaminergic neurons loss in PD patients [201].”
BackgroundPlasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676 · cited 3×
“Notably, exosomal α-syn has been proposed as a potential biomarker for PD in multiple studies [238,239,246,264].”
BackgroundNeuroinflammation in Parkinson's disease
Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 657
Pathological sequelae of long-haul COVID
Mehandru, S., & Merad, M. (2022) · Nature Immunology · doi:10.1038/s41590-021-01104-y · Cited by 657
Yang, L., Han, Y., Nilsson-Payant, B. E., Gupta, V., Wang, P., Duan, X., Tang, X., Zhu, J., Zhao, Z., Jaffré, F., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.06.015 · Cited by 642 · cited 1×
“Induced pluripotent stem cells (IPCS) derived from midbrain dopaminergic neurons were shown to be vulnerable to SARS-CoV-2 infection in vitro [158], unravelling the potentially direct neurotrophic effect of SARS-CoV-2 in strategic PD areas.”
BackgroundCell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
Guo, J. L., & Lee, V. M. Y. (2014) · Nature Medicine · doi:10.1038/nm.3457 · Cited by 641
Gould, S. J., Booth, A. M., & Hildreth, J. E. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1831413100 · Cited by 638 · cited 1×
“The “Trojan exosome hypothesis”, in which retroviruses employ EVs to penetrate host cells, boost viral propagation, and elude the immune response, was introduced by Gould and colleagues [286] and was later supported by several reports [40].”
BackgroundRecasens, A., Dehay, B., Bové, J., Carballo‐Carbajal, I., Dovero, S., Pérez‐Villalba, A., Fernagut, P., Blesa, J., Parent, A., Perier, C., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24066 · Cited by 632
Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline
Shah, W., Hillman, T., Playford, E. D., & Hishmeh, L. (2021) · BMJ · doi:10.1136/bmj.n136 · Cited by 631
Colonic inflammation in Parkinson's disease
Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627 · cited 1×
“GI symptoms and intestinal inflammation may emerge years before clinical indications of PD become apparent [94,95].”
BackgroundProtein transmission in neurodegenerative disease
Peng, C., Trojanowski, J. Q., & Lee, V. M.-Y. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0333-7 · Cited by 625 · cited 1×
“Unlike other cell-to-cell transmission mechanisms, such as non-classical exocytosis or transport via nanotubules, exosomes can mediate α-syn transfer over longer distances [241].”
BackgroundSystematic review of incidence studies of Parkinson's disease
Twelves, D., Perkins, K. S. M., & Counsell, C. (2003) · Movement Disorders · doi:10.1002/mds.10305 · Cited by 622 · cited 1×
“5–1% among those 65–69 years of age, rising to 3% among persons of 80 years and older [6], with an annual incidence rate of approximately 11–19/100,000 cases per year [7,8].”
BackgroundDysregulation of brain and choroid plexus cell types in severe COVID-19
Yang, A. C., Kern, F., Losada, P. M., Agam, M. R., Maat, C. A., Schmartz, G. P., Fehlmann, T., Stein, J. A., Schaum, N., Lee, D. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03710-0 · Cited by 620 · cited 1×
“The ensuing dysregulation of homeostatic pathways could potentially lead to neurodegeneration [148].”
BackgroundA Molecular Web: Endoplasmic Reticulum Stress, Inflammation, and Oxidative Stress
Chaudhari, N., Talwar, P., Parimisetty, A., Lefebvre d’Hellencourt, C., & Ravanan, P. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00213 · Cited by 600 · cited 1×
“Aside from initiating apoptotic pathways, ER stress is a powerful stimulator of NF-κB activation and inflammatory gene transcription [198,199].”
BackgroundPathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia
Bianco, F., Pravettoni, E., Colombo, A., Schenk, U., Möller, T., Matteoli, M., & Verderio, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7268 · Cited by 596
Posey, K. A., Clegg, D. J., Printz, R. L., Byun, J., Morton, G. J., Vivekanandan-Giri, A., Pennathur, S., Baskin, D. G., Heinecke, J. W., Woods, S. C., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90377.2008 · Cited by 586 · cited 1×
“Experimental studies in other several systemic inflammatory conditions, such as obesity [296] and rheumatoid arthritis [297], have outlined a strong relationship between peripheral systemic inflammation and neuroinflammation [298,299].”
BackgroundThe impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
Hirsch, L., Jette, N., Frolkis, A., Steeves, T., & Pringsheim, T. (2016) · Neuroepidemiology · doi:10.1159/000445751 · Cited by 571 · cited 1×
“5–1% among those 65–69 years of age, rising to 3% among persons of 80 years and older [6], with an annual incidence rate of approximately 11–19/100,000 cases per year [7,8].”
BackgroundThe Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
Chen, R., Wang, K., Yu, J., Howard, D., French, L., Chen, Z., Wen, C., & Xu, Z. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573095 · Cited by 570
Henry, C. J., Huang, Y., Wynne, A. M., & Godbout, J. P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.09.002 · Cited by 565 · cited 1×
“Experimental studies in other several systemic inflammatory conditions, such as obesity [296] and rheumatoid arthritis [297], have outlined a strong relationship between peripheral systemic inflammation and neuroinflammation [298,299].”
BackgroundBanks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124407 · Cited by 561 · cited 1×
“Considering that exosomes can cross the BBB and act as fingerprints of their cellular originators, they could be used as CNS biomarkers that can be isolated and recovered from the periphery, with minimally invasive techniques [234].”
BackgroundAltered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
Gui, Y., Liu, H., Zhang, L., Lv, W., & Hu, X. (2015) · Oncotarget · doi:10.18632/oncotarget.6158 · Cited by 552 · cited 1×
“10a-5p, and let-7g-3p, on the other hand, were increased in that patient group [275].”
BackgroundChinta, S. J., Woods, G., Demaria, M., Rane, A., Zou, Y., McQuade, A., Rajagopalan, S., Limbad, C., Madden, D. T., Campisi, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.092 · Cited by 530 · cited 2×
“Depending on the cargo and cell of origin, exosomes may conversely ameliorate the SASP [259], thereby abating inflammation [260,261].”
BackgroundMicroglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K. (2020) · Brain · doi:10.1093/brain/awaa090 · Cited by 522 · cited 2×
“Furthermore, exogenous introduction of human α-syn preformed fibrils (PFFs) into primary microglial cell cultures stimulates the release of α-syn-containing exosomes, which were fully capable of inducing protein aggregation in recipient neurons [255].”
BackgroundSchurink, B., Roos, E., Radonic, T., Barbe, E., Bouman, C. S. C., de Boer, H. H., de Bree, G. J., Bulle, E. B., Aronica, E. M., Florquin, S., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30144-0 · Cited by 512 · cited 1×
“Regardless of COVID-19 disease severity, significant inflammatory responses such as astrogliosis, microglia activation, and perivascular T-lymphocyte infiltration were observed postmortem in both white and gray matter of patient brains [147].”
BackgroundLow clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
Adler, C. H., Beach, T. G., Hentz, J. G., Shill, H. A., Caviness, J. N., Driver-Dunckley, E., Sabbagh, M. N., Sue, L. I., Jacobson, S. A., Belden, C. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000641 · Cited by 503 · cited 1×
“Hence, a low clinical diagnostic accuracy rate in the preclinical phase has been reported [263].”
BackgroundExtracellular vesicles and viruses: Are they close relatives?
Nolte-‘t Hoen, E., Cremer, T., Gallo, R. C., & Margolis, L. B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605146113 · Cited by 494 · cited 1×
“Exosomes and viruses share structural and physicochemical features, such as size, shape, biochemical composition, and biomolecule transportation pathways within cells [279,280].”
BackgroundIs alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases
Shannon, K. M., Keshavarzian, A., Dodiya, H. B., Jakate, S., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.25020 · Cited by 464
Jang, H., Boltz, D., Sturm-Ramirez, K., Shepherd, K. R., Jiao, Y., Webster, R., & Smeyne, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900096106 · Cited by 459 · cited 8×
“In PD studies, mitochondrial dysfunction may occur months before the onset of striatal dopaminergic neuron loss [175] and PD patients have been well documented to possess reduced or deficient mitochondrial complex I activity in the SNpc [176,177].”
BackgroundInfluentialStuendl, A., Kunadt, M., Kruse, N., Bartels, C., Moebius, W., Danzer, K. M., Mollenhauer, B., & Schneider, A. (2016) · Brain · doi:10.1093/brain/awv346 · Cited by 428 · cited 2×
“Notably, exosomal α-syn has been proposed as a potential biomarker for PD in multiple studies [238,239,246,264].”
BackgroundThe spectrum of nonmotor symptoms in early Parkinson disease
Khoo, T. K., Yarnall, A. J., Duncan, G. W., Coleman, S., O’Brien, J. T., Brooks, D. J., Barker, R. A., & Burn, D. J. (2013) · Neurology · doi:10.1212/wnl.0b013e31827deb74 · Cited by 427 · cited 1×
“However, prior to motor manifestation onset, patients may display non-motor symptoms such as hyposmia, gastrointestinal dysfunction, and sleep disorders [12].”
BackgroundPang, S. Y.-Y., Ho, P. W.-L., Liu, H.-F., Leung, C.-T., Li, L., Chang, E. E. S., Ramsden, D. B., & Ho, S.-L. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0165-9 · Cited by 427 · cited 1×
“PD is a disease of multicomplex etiology, involving the interaction of aging, genetics, and environmental variables, as well as infectious agents, such as viral infections [13,14].”
BackgroundGenetic and environmental factors in the cause of Parkinson's disease
Warner, T. T., & Schapira, A. H. V. (2003) · Annals of Neurology · doi:10.1002/ana.10487 · Cited by 399
COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital
Thakur, K. T., Miller, E. H., Glendinning, M. D., Al-Dalahmah, O., Banu, M. A., Boehme, A. K., Boubour, A. L., Bruce, S. S., Chong, A. M., Claassen, J., et al. (2021) · Brain · doi:10.1093/brain/awab148 · Cited by 393 · cited 1×
“Indeed, a COVID-19 postmortem study detected major neurological damage, but only low levels of SARS-CoV-2 RNA in the brains of expired patients [325].”
BackgroundParkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder?
Olanow, C. W., & Brundin, P. (2013) · Movement Disorders · doi:10.1002/mds.25373 · Cited by 390 · cited 1×
“The “prion-like” mode of α-syn spread lies at the heart of PD pathogenesis, as the molecular mechanisms leading to α-syn seeding and aggregation remain unknown [240].”
BackgroundComplex I deficiency in Parkinson's disease frontal cortex
Parker, W. D., Parks, J. K., & Swerdlow, R. H. (2008) · Brain Research · doi:10.1016/j.brainres.2007.10.061 · Cited by 382 · cited 8×
“In PD studies, mitochondrial dysfunction may occur months before the onset of striatal dopaminergic neuron loss [175] and PD patients have been well documented to possess reduced or deficient mitochondrial complex I activity in the SNpc [176,177].”
BackgroundInfluentialDecoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis
Singh, K. K., Chaubey, G., Chen, J. Y., & Suravajhala, P. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00224.2020 · Cited by 382 · cited 1×
“SARS-CoV-2 seems to interact with and manipulate mitochondria in order to hijack and evade mitochondria-mediated immune response for its own replication and survival [179,180].”
BackgroundEbrahimi-Fakhari, D., Cantuti-Castelvetri, I., Fan, Z., Rockenstein, E., Masliah, E., Hyman, B. T., McLean, P. J., & Unni, V. K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1560-11.2011 · Cited by 377 · cited 1×
“The ubiquitin–proteasome system (UPS) and the autophagy–lysosomal pathway (ALP) are important proteolytic systems in neurons and critical for refolding or elimination of misfolded proteins; therefore, they play a significant role in cellular homeostasis [205].”
BackgroundRelationship between the gut microbiome and brain function
Mohajeri, M. H., La Fata, G., Steinert, R. E., & Weber, P. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy009 · Cited by 376 · cited 1×
“This warrants further investigation because GI microbiota equilibrium plays an important role in several physiological processes ensuring brain integrity and neurogenesis [109,110].”
BackgroundYachou, Y., El Idrissi, A., Belapasov, V., & Ait Benali, S. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04575-3 · Cited by 375 · cited 1×
“Indeed, growing evidence indicates that SARS-CoV-2 induces neuroinflammation [114] through its neurotropic, neuroinvasive, and neurovirulence effects [115,116] or even via immune-mediated pathways [117].”
BackgroundBraak, H., & Del Tredici, K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179001 · Cited by 372
Epidemiology of Parkinson Disease
Lee, A., & Gilbert, R. M. (2016) · Neurologic Clinics · doi:10.1016/j.ncl.2016.06.012 · Cited by 366 · cited 1×
“5–1% among those 65–69 years of age, rising to 3% among persons of 80 years and older [6], with an annual incidence rate of approximately 11–19/100,000 cases per year [7,8].”
BackgroundNeurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Marogianni, C., Sokratous, M., Dardiotis, E., Hadjigeorgiou, G. M., Bogdanos, D., & Xiromerisiou, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228421 · Cited by 366 · cited 9×
“In PD studies, mitochondrial dysfunction may occur months before the onset of striatal dopaminergic neuron loss [175] and PD patients have been well documented to possess reduced or deficient mitochondrial complex I activity in the SNpc [176,177].”
BackgroundInfluentialSelf-citationMultiple organ involvement by alpha-synuclein pathology in lewy body disorders
Gelpi, E., Navarro‐Otano, J., Tolosa, E., Gaig, C., Compta, Y., Rey, M. J., Martí, M. J., Hernández, I., Valldeoriola, F., Reñé, R., et al. (2014) · Movement Disorders · doi:10.1002/mds.25776 · Cited by 361 · cited 1×
“structures [101,102] and they constitute principal areas of LB accumulation, even at the earliest stages of disease development [91].”
BackgroundHarapan, B. N., & Yoo, H. J. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10406-y · Cited by 359
Koprich, J. B., Reske-Nielsen, C., Mithal, P., & Isacson, O. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-8 · Cited by 355
Santa Cruz, A., Mendes-Frias, A., Oliveira, A. I., Dias, L., Matos, A. R., Carvalho, A., Capela, C., Pedrosa, J., Castro, A. G., & Silvestre, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613422 · Cited by 355
Miao, G., Zhao, H., Li, Y., Ji, M., Chen, Y., Shi, Y., Bi, Y., Wang, P., & Zhang, H. (2021) · Developmental Cell · doi:10.1016/j.devcel.2020.12.010 · Cited by 354 · cited 1×
“Remarkably, this feature of HOPS-VPS39-mediated A-L fusion inhibition appears to be unique to SARS-CoV-2, since the quite similar ORF3a of SARS-CoV was ineffective in inhibiting A-L fusion [209].”
BackgroundMitochondrial Functions in Infection and Immunity
Tiku, V., Tan, M.-W., & Dikic, I. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.006 · Cited by 352 · cited 1×
“Finally, mitochondria aid the antiviral immune response by allowing release of proinflammatory cytokines [186].”
BackgroundAboudounya, M. M., & Heads, R. J. (2021) · Mediators of Inflammation · doi:10.1155/2021/8874339 · Cited by 346
Lysosomal impairment in Parkinson's disease
Dehay, B., Martinez‐Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., Klein, C., Vila, M., & Bezard, E. (2013) · Movement Disorders · doi:10.1002/mds.25462 · Cited by 340 · cited 1×
“Impairment or even failure of these systems may contribute to PD pathogenesis and progression [21,206].”
BackgroundExosomes as mediators of neuroinflammation
Gupta, A., & Pulliam, L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-68 · Cited by 328 · cited 1×
“In addition, exosomes generated by peripheral immune cells, such as activated monocytes and macrophages, were shown to be taken up by neurons and astrocytes, resulting in pathological cargo dissemination and neurotoxicity [301].”
BackgroundPeripheral Inflammatory Biomarkers and Risk of Parkinson's Disease
Chen, H., O'Reilly, E. J., Schwarzschild, M. A., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm260 · Cited by 317 · cited 1×
“Interestingly, a small prospective observational study had previously found that high levels of IL-6 were linked to a higher chance of developing PD [124].”
BackgroundBorghesan, M., Fafián-Labora, J., Eleftheriadou, O., Carpintero-Fernández, P., Paez-Ribes, M., Vizcay-Barrena, G., Swisa, A., Kolodkin-Gal, D., Ximénez-Embún, P., Lowe, R., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.095 · Cited by 315 · cited 1×
“Notably, interferon-responsive genes and proteins, such as the IFITM3 protein, may be loaded during such transmissions, representing a tissue-level signal of inflammation [258].”
BackgroundCersosimo, M. G., Raina, G. B., Pecci, C., Pellene, A., Calandra, C. R., Gutiérrez, C., Micheli, F. E., & Benarroch, E. E. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6801-2 · Cited by 314 · cited 1×
“GI symptoms and intestinal inflammation may emerge years before clinical indications of PD become apparent [94,95].”
BackgroundRole of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review
Suhail, S., Zajac, J., Fossum, C., Lowater, H., McCracken, C., Severson, N., Laatsch, B., Narkiewicz-Jodko, A., Johnson, B., Liebau, J., et al. (2020) · The Protein Journal · doi:10.1007/s10930-020-09935-8 · Cited by 306
CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
Williams, G. P., Schonhoff, A. M., Jurkuvenaite, A., Gallups, N. J., Standaert, D. G., & Harms, A. S. (2021) · Brain · doi:10.1093/brain/awab103 · Cited by 306 · cited 1×
“The ensuing neuroinflammation and dopaminergic neuron loss in the SNpc could conceivably lead to a PD phenotype [308,309].”
BackgroundGangoda, L., Boukouris, S., Liem, M., Kalra, H., & Mathivanan, S. (2015) · PROTEOMICS · doi:10.1002/pmic.201400234 · Cited by 301
Cytokines: Powerful Regulators of Glial Cell Activation
John, G. R., Lee, S. C., & Brosnan, C. F. (2003) · The Neuroscientist · doi:10.1177/1073858402239587 · Cited by 300 · cited 1×
“In that case, the CNS professional immune cells, microglia and astrocytes, may also become activated [133,134].”
BackgroundParkinson’s Disease: Pathogenesis and Clinical Aspects
(2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018 · Cited by 294
Extracellular vesicles: structure, function, and potential clinical uses in renal diseases
Borges, F. T., Reis, L. A., & Schor, N. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132964 · Cited by 292 · cited 3×
“Then, budding and modification of the limiting membran of endosomes leads to formation of intralu inal vesicles (ILVs), whose accumulation pro uces late endosomes or large multivesicular bodies (M Bs) [221,223].”
BackgroundSample Preparation and Imaging of Exosomes by Transmission Electron Microscopy
Jung, M. K., & Mun, J. Y. (2018) · Journal of Visualized Experiments · doi:10.3791/56482 · Cited by 285 · cited 2×
“Exosomes are EVs [219] with a cup-shaped appearance in transmission electron microscopy and siz ranging from 30 to 150 nm [220,221].”
BackgroundLam, S. M., Zhang, C., Wang, Z., Ni, Z., Zhang, S., Yang, S., Huang, X., Mo, L., Li, J., Lee, B., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00425-4 · Cited by 284 · cited 1×
“Monosialodihexosyl ganglioside (GM3)-enriched exosomes are positively connected with disease severity in COVID-19 cases [293].”
BackgroundCellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281 · cited 2×
“Finally, cellular senescence is a core homeostatic event that provides yet another, ageand state-dependent substrate for neurodegeneration and the development of diseases like AD and PD [141,142].”
BackgroundChernyak, B. V., Popova, E. N., Prikhodko, A. S., Grebenchikov, O. A., Zinovkina, L. A., & Zinovkin, R. A. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920120068 · Cited by 280
The prion hypothesis in Parkinson's disease: braak to the future
Visanji, N. P., Brooks, P. L., Hazrati, L.-N., & Lang, A. E. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-2 · Cited by 278
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease
Hattori, N., Tanaka, M., Ozawa, T., & Mizuno, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410300409 · Cited by 276 · cited 8×
“In PD studies, mitochondrial dysfunction may occur months before the onset of striatal dopaminergic neuron loss [175] and PD patients have been well documented to possess reduced or deficient mitochondrial complex I activity in the SNpc [176,177].”
BackgroundInfluentialSerum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
Jiang, C., Hopfner, F., Katsikoudi, A., Hein, R., Catli, C., Evetts, S., Huang, Y., Wang, H., Ryder, J. W., Kuhlenbaeumer, G., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322588 · Cited by 275 · cited 1×
“Mean levels of neuron-derived exosomal α-syn have been proposed to distinguish PD from other cases of atypical parkinsonism and neurodegenerative diseases, as a twofold increase was observed in patients with preclinical and established PD compared to the other etiologies [266].”
ResultJang, H., Boltz, D. A., Webster, R. G., & Smeyne, R. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.001 · Cited by 273 · cited 3×
“Additionally, there is now a wide range of data to support the existence of viral parkinsonism, which often manifests following recovery from viral infections [4].”
BackgroundInfluentialIntegrating Pathways of Parkinson's Disease in a Molecular Interaction Map
Fujita, K. A., Ostaszewski, M., Matsuoka, Y., Ghosh, S., Glaab, E., Trefois, C., Crespo, I., Perumal, T. M., Jurkowski, W., Antony, P. M. A., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8489-4 · Cited by 273
Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery
van Dongen, H. M., Masoumi, N., Witwer, K. W., & Pegtel, D. M. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00063-15 · Cited by 265 · cited 1×
“Exosomes and viruses share structural and physicochemical features, such as size, shape, biochemical composition, and biomolecule transportation pathways within cells [279,280].”
BackgroundTerlecki-Zaniewicz, L., Lämmermann, I., Latreille, J., Bobbili, M. R., Pils, V., Schosserer, M., Weinmüllner, R., Dellago, H., Skalicky, S., Pum, D., et al. (2018) · Aging · doi:10.18632/aging.101452 · Cited by 246 · cited 1×
“Depending on the cargo and cell of origin, exosomes may conversely ameliorate the SASP [259], thereby abating inflammation [260,261].”
BackgroundThe involvement of microRNAs in neurodegenerative diseases
Maciotta, S., Meregalli, M., & Torrente, Y. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00265 · Cited by 245 · cited 1×
“Mounting evidence has proposed a pivotal role for exosomal miRNAs in neurodegenerative diseases, including PD [271].”
BackgroundNeurovascular Unit Dysfunction and Neurodegenerative Disorders
Yu, X., Ji, C., & Shao, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00334 · Cited by 244 · cited 1×
“NVU disruption has been previously associated with neurodegenerative diseases [128].”
BackgroundCNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges
Hornung, S., Dutta, S., & Bitan, G. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00038 · Cited by 238 · cited 1×
“The usage of exosomes for the removal of accumulated, misfolded proteins increases under pathological conditions, particularly in proteinopathies [235,236].”
BackgroundOlfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders
The Arizona Parkinson’s Disease Consortium, Beach, T. G., White, C. L., Hladik, C. L., Sabbagh, M. N., Connor, D. J., Shill, H. A., Sue, L. I., Sasse, J., Bachalakuri, J., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0450-7 · Cited by 235 · cited 1×
“In fact, it was suggested that the extent of α-synucleinopathy in the olfactory bulb strongly predicts the neuropathological confirmation of PD and reflects the severity of α-synucleinopathy in other brain regions [93].”
BackgroundThe Evolution of Diagnosis in Early Parkinson Disease
Jankovic, J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.3.369 · Cited by 229
Role of Exosomes in Central Nervous System Diseases
Liu, W., Bai, X., Zhang, A., Huang, J., Xu, S., & Zhang, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00240 · Cited by 221 · cited 2×
“The usage of exosomes for the removal of accumulated, misfolded proteins increases under pathological conditions, particularly in proteinopathies [235,236].”
BackgroundThe neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
Bauer, L., Laksono, B. M., de Vrij, F. M. S., Kushner, S. A., Harschnitz, O., & van Riel, D. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.02.006 · Cited by 217 · cited 1×
“Indeed, growing evidence indicates that SARS-CoV-2 induces neuroinflammation [114] through its neurotropic, neuroinvasive, and neurovirulence effects [115,116] or even via immune-mediated pathways [117].”
BackgroundSingh, S. S., Rai, S. N., Birla, H., Zahra, W., Rathore, A. S., & Singh, S. P. (2020) · Neurotoxicity Research · doi:10.1007/s12640-019-00147-2 · Cited by 215 · cited 1×
“Hence, deregulation of this signaling pathway has been linked to PD onset and pathology [202] by favoring α-syn accumulation, aggregation, and spreading, oxidative stress-induced neuron apoptosis, neuroinflammation, and dopaminergic neuron loss [139,203,204].”
BackgroundAlpha-Synuclein Expression Restricts RNA Viral Infections in the Brain
Beatman, E. L., Massey, A., Shives, K. D., Burrack, K. S., Chamanian, M., Morrison, T. E., & Beckham, J. D. (2016) · Journal of Virology · doi:10.1128/jvi.02949-15 · Cited by 214 · cited 1×
“This notion was supported by in vivo experiments, where WNV-infected α-syn-knockout mice showed decreased survival compared to the control group [57].”
ResultShi, M., Kovac, A., Korff, A., Cook, T. J., Ginghina, C., Bullock, K. M., Yang, L., Stewart, T., Zheng, D., Aro, P., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.003 · Cited by 206
Li, J. J., Wang, B., Kodali, M. C., Chen, C., Kim, E., Patters, B. J., Lan, L., Kumar, S., Wang, X., Yue, J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1038-8 · Cited by 204 · cited 1×
“Specifically, in a mouse model that received serum-derived exosomes from lipopolysaccharide (LPS)-challenged mice, brain gliosis, CNS expression of pro-inflammatory cytokine mRNA and inflammationassociated miR-155 were all increased [300].”
BackgroundSmall Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage
Fafián-Labora, J. A., Rodríguez-Navarro, J. A., & O’Loghlen, A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.004 · Cited by 203
Bordt, E. A., & Polster, B. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.033 · Cited by 202
Xia, X., Wang, Y., Huang, Y., Zhang, H., Lu, H., & Zheng, J. C. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101694 · Cited by 202 · cited 1×
“Exosomal miRNAs regulate gene expression in recipient cells at a post-transcriptional level, thereby interfering with several physiological processes in the CNS, including homeostasis, neuron growth, cell migration, and brain endogenous immunity [270].”
BackgroundGlia and alpha-synuclein in neurodegeneration: A complex interaction
Brück, D., Wenning, G. K., Stefanova, N., & Fellner, L. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.003 · Cited by 202 · cited 1×
“By phagocytosing dead cells and helping with the removal of misfolded protein aggregates from the brain, they play an important role in the removal of extracellular α-syn species, including exosomecontained protein [252].”
BackgroundCirculating Exosomes Are Strongly Involved in SARS-CoV-2 Infection
Barberis, E., Vanella, V. V., Falasca, M., Caneapero, V., Cappellano, G., Raineri, D., Ghirimoldi, M., De Giorgis, V., Puricelli, C., Vaschetto, R., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.632290 · Cited by 202
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease
Fazzini, E., Fleming, J., & Fahn, S. (1992) · Movement Disorders · doi:10.1002/mds.870070210 · Cited by 193 · cited 1×
“The relationship between other members of the human Coronaviridae family, such as OC43 and 229E, and PD has been previously described, since antibodies against these coronaviruses were found in the cerebrospinal fluid (CSF) of PD patients [60].”
BackgroundCellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Zeng, X.-S., Geng, W.-S., Jia, J.-J., Chen, L., & Zhang, P.-P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00109 · Cited by 193
HMGB1 in Development and Diseases of the Central Nervous System
Fang, P., Schachner, M., & Shen, Y.-Q. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8264-y · Cited by 193 · cited 1×
“High-mobility group box 1 (HMGB1) is a nuclear protein involved in several CNS procedures such as inflammation, apoptosis, and autophagy regulation [310].”
BackgroundA case of probable Parkinson's disease after SARS-CoV-2 infection
Cohen, M. E., Eichel, R., Steiner-Birmanns, B., Janah, A., Ioshpa, M., Bar-Shalom, R., Paul, J. J., Gaber, H., Skrahina, V., Bornstein, N. M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30305-7 · Cited by 192
Enteric GFAP expression and phosphorylation in Parkinson's disease
Clairembault, T., Kamphuis, W., Leclair‐Visonneau, L., Rolli‐Derkinderen, M., Coron, E., Neunlist, M., Hol, E. M., & Derkinderen, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12742 · Cited by 191 · cited 1×
“Specifically, microglia and astrocytic subpopulations were enriched by inflammatory genes and deregulated neuroprotective ones that had been previously linked to PD and other human neurodegenerative diseases, such as the glial fibrillary acidic protein (GFAP), the interferoninduced transmembrane protein-3 (IFITM3), an…”
BackgroundHuman Saliva-Derived Exosomes: Comparing Methods of Isolation
Zlotogorski-Hurvitz, A., Dayan, D., Chaushu, G., Korvala, J., Salo, T., Sormunen, R., & Vered, M. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414564219 · Cited by 191
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
Troncoso-Escudero, P., Parra, A., Nassif, M., & Vidal, R. L. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00860 · Cited by 191
Sun, B., Tang, N., Peluso, M. J., Iyer, N. S., Torres, L., Donatelli, J. L., Munter, S. E., Nixon, C. C., Rutishauser, R. L., Rodriguez-Barraquer, I., et al. (2021) · Cells · doi:10.3390/cells10020386 · Cited by 188
Musgrove, R. E., Helwig, M., Bae, E.-J., Aboutalebi, H., Lee, S.-J., Ulusoy, A., & Di Monte, D. A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127330 · Cited by 187 · cited 1×
“In vitro investigations have demonstrated that DMV neurons are vulnerable to oxidative stress and that oxidative stress enhances intercellular α-syn propagation [331].”
BackgroundEffects of COVID‐19 on Parkinson's Disease Clinical Features: A Community‐Based Case‐Control Study
Cilia, R., Bonvegna, S., Straccia, G., Andreasi, N. G., Elia, A. E., Romito, L. M., Devigili, G., Cereda, E., & Eleopra, R. (2020) · Movement Disorders · doi:10.1002/mds.28170 · Cited by 185 · cited 1×
“In addition, SARS-CoV-2 infection has been demonstrated to significantly worsen motor and non-motor symptoms in people with pre-existing PD [79,80].”
BackgroundViana, S. D., Nunes, S., & Reis, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101123 · Cited by 185 · cited 1×
“On top of that, gut microbiota imbalance due to extrapulmonary SARS-CoV-2 infection has also been observed in COVID-19 [107,108].”
BackgroundIslam, H., Chamberlain, T. C., Mui, A. L., & Little, J. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.677008 · Cited by 182
Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes
Bliederhaeuser, C., Grozdanov, V., Speidel, A., Zondler, L., Ruf, W. P., Bayer, H., Kiechle, M., Feiler, M. S., Freischmidt, A., Brenner, D., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1504-2 · Cited by 180 · cited 1×
“This glia-derived insidious exosomal cargo can spread to neurons, contributing to a vicious cycle of neuroinflammation and neurodegeneration [245], a phenomenon further associated with older age [303].”
BackgroundNiu, M., Li, Y., Li, G., Zhou, L., Luo, N., Yao, M., Kang, W., & Liu, J. (2020) · European Journal of Neurology · doi:10.1111/ene.14208 · Cited by 178 · cited 2×
“Notably, exosomal α-syn has been proposed as a potential biomarker for PD in multiple studies [238,239,246,264].”
BackgroundThe Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
Brown, E. G., Chahine, L. M., Goldman, S. M., Korell, M., Mann, E., Kinel, D. R., Arnedo, V., Marek, K. L., & Tanner, C. M. (2020) · Journal of Parkinson's Disease · doi:10.3233/jpd-202249 · Cited by 177 · cited 1×
“In addition, SARS-CoV-2 infection has been demonstrated to significantly worsen motor and non-motor symptoms in people with pre-existing PD [79,80].”
BackgroundZhao, Z.-H., Chen, Z.-T., Zhou, R.-L., Zhang, X., Ye, Q.-Y., & Wang, Y.-Z. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00438 · Cited by 176
Frank, M. G., Nguyen, K. H., Ball, J. B., Hopkins, S., Kelley, T., Baratta, M. V., Fleshner, M., & Maier, S. F. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.12.007 · Cited by 175 · cited 1×
“Interestingly, the S1 subunit of S protein was found to efficiently trigger neuroinflammation, including microglia activation, release of multiple pro-inflammatory cytokines, and cause behavioral deficits in rats [138].”
BackgroundModes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions
Zhou, L., Ayeh, S. K., Chidambaram, V., & Karakousis, P. C. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06222-4 · Cited by 174 · cited 1×
“SARS-CoV-2 spreads via infected secretions, such as saliva and respiratory droplets, through direct, indirect, or close contact with infected patients, even if COVID-19 symptomatology is absent [64,65].”
BackgroundRastogi, S., Sharma, V., Bharti, P. S., Rani, K., Modi, G. P., Nikolajeff, F., & Kumar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010440 · Cited by 174 · cited 3×
“Exosomes, the nanosized vesicles and masters of intercellular communication [31], have been proposed to serve as an efficient “vehicle” of transportation for such proteins [32], mainly because they are a priori involved in several homeostatic procedures in the central nervous system (CNS) including myelination mainten…”
BackgroundAcute hypokinetic-rigid syndrome following SARS-CoV-2 infection
Méndez-Guerrero, A., Laespada-García, M. I., Gómez-Grande, A., Ruiz-Ortiz, M., Blanco-Palmero, V. A., Azcarate-Diaz, F. J., Rábano-Suárez, P., Álvarez-Torres, E., de Fuenmayor-Fernández de la Hoz, C. P., Vega Pérez, D., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010282 · Cited by 169
Exosomes of BV-2 cells induced by alpha-synuclein: Important mediator of neurodegeneration in PD
Chang, C., Lang, H., Geng, N., Wang, J., Li, N., & Wang, X. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.009 · Cited by 168 · cited 2×
“This glia-derived insidious exosomal cargo can spread to neurons, contributing to a vicious cycle of neuroinflammation and neurodegeneration [245], a phenomenon further associated with older age [303].”
BackgroundKuate, S., Cinatl, J., Doerr, H. W., & Überla, K. (2007) · Virology · doi:10.1016/j.virol.2006.12.011 · Cited by 167 · cited 1×
“In SARS-CoV-2 infection, exosomal cargo contains viral proteins or peptide fragments, such as the N and S proteins [282,283], whose presence has been linked to enhanced viral propagation, host immune reaction, and induction of a cytokine storm [284].”
Backgroundα-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson’s disease
Cao, Z., Wu, Y., Liu, G., Jiang, Y., Wang, X., Wang, Z., & Feng, T. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.030 · Cited by 162 · cited 1×
“In salivary EVs from PD patients, it was demonstrated that absolute levels of α-syn oligomers and the ratio of α-syn oligomers over total α-syn were increased compared to healthy controls, indicating that they could be used as diagnostic biomarkers [265].”
BackgroundNeuroinflammation During RNA Viral Infections
Klein, R. S., Garber, C., Funk, K. E., Salimi, H., Soung, A., Kanmogne, M., Manivasagam, S., Agner, S., & Cain, M. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041417 · Cited by 160 · cited 1×
“However, inflammation affects BBB integrity and stability mainly through cytokine-induced degradation of TJ proteins [129].”
BackgroundLinking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
Colla, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00560 · Cited by 159 · cited 1×
“Endoplasmic reticulum (ER) stress has been linked to neurodegenerative diseases, including PD [190,191].”
BackgroundThe Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Hsu, R., Yu, W.-C., Peng, G.-R., Ye, C.-H., Hu, S., Chong, P. C. T., Yap, K. Y., Lee, J. Y. C., Lin, W., & Yu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832394 · Cited by 159 · cited 1×
“Evidently, an exacerbated systemic infection that causes a huge release of inflammatory mediators, including cytokines, chemokines, and antibodies, could lead to increased blood–brain barrier (BBB) permeability [125].”
BackgroundInteractions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation
Semerdzhiev, S. A., Fakhree, M. A. A., Segers‐Nolten, I. M. J., Blum, C., & Claessens, M. M. A. E. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00666 · Cited by 158 · cited 2×
“This hypothesis could be supported by the fact that both viral proteins have been shown to increase total α-syn and phosphorylation at Ser129 (pS129) levels [332], speed up the ability of endogenous α-syn to form amyloid fibrils [167], and ultimately induce LB-like pathology [332].”
BackgroundResultSTAT1 drives M1 microglia activation and neuroinflammation under hypoxia
Butturini, E., Boriero, D., Carcereri de Prati, A., & Mariotto, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.05.011 · Cited by 154
Ottum, P. A., Arellano, G., Reyes, L. I., Iruretagoyena, M., & Naves, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00539 · Cited by 153 · cited 2×
“SARS-CoV-2 could exploit inflammatory exosomal cargo [306] to induce oxidative stress in the DMV, facilitate α-syn aggregation, and eventually promote post-COVID-19 parkinsonism through SARS-CoV-2 S and N proteins.”
BackgroundParkinsonism with HIV infection
Mirsattari, S. M., Power, C., & Nath, A. (1998) · Movement Disorders · doi:10.1002/mds.870130413 · Cited by 150 · cited 2×
“such as hepatitis C virus (HCV) [42], herpes simplex virus-1 (HSV-1) [43], human immunodeficiency virus (HIV) [44], varicella-zoster virus (VZV) [45], West Nile virus (WNV) [46], Japanese encephalitis virus (JEV) [47,48], and Epstein–Barr virus (EBV) [49], have all been cited as risk factors for PD development or park…”
BackgroundEarnest, J. T., Hantak, M. P., Li, K., McCray, P. B., Perlman, S., & Gallagher, T. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006546 · Cited by 150 · cited 1×
“In addition, CD9 cooperates with TMPRSS2 to cleave viral fusion glycoproteins, thus facilitating the entry of coronaviruses, such as MERS-CoV, into lung cells [292].”
BackgroundSilent hypoxia in COVID-19: pathomechanism and possible management strategy
Rahman, A., Tabassum, T., Araf, Y., Al Nahid, A., Ullah, M. A., & Hosen, M. J. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06358-1 · Cited by 150
Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease
Sasaki, T., Liu, K., Agari, T., Yasuhara, T., Morimoto, J., Okazaki, M., Takeuchi, H., Toyoshima, A., Sasada, S., Shinko, A., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.11.003 · Cited by 149 · cited 1×
“Notably, inhibition of HMGB1 has been shown to reduce microglia-mediated neuroinflammation, neuron dopaminergic loss, and progression of PD pathology in PD animal models [311,312].”
BackgroundNeurological complications and infection mechanism of SARS-CoV-2
Wan, D., Du, T., Hong, W., Chen, L., Que, H., Lu, S., & Peng, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00818-7 · Cited by 149 · cited 1×
“ACE2 is highly expressed in several brain areas [153], including striatum [154], the substantia nigra, the olfactory bulb [155], and the brain endothelium [130,156,157].”
BackgroundHou, P., Wang, X., Wang, H., Wang, T., Yu, Z., Xu, C., Zhao, Y., Wang, W., Zhao, Y. B., Chu, F., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2084686 · Cited by 146 · cited 1×
“Furthermore, another study found that although ORF7a protein stimulates autophagy, it also limits A-L fusion progression by downregulating the SNAP29 protein via caspase 3 (CASP3) activation, providing a mechanism through which SARSCoV-2 uses the autophagic system to facilitate its own propagation [210].”
BackgroundThe Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases
Wang, X., Zhou, Y., Gao, Q., Ping, D., Wang, Y., Wu, W., Lin, X., Fang, Y., Zhang, J., & Shao, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3232869 · Cited by 144 · cited 1×
“Secondly, they can directly bind to TLRs and trigger neuroinflammation [273], and thirdly, they can induce oxidative stress pathways leading to neurotoxicity [274].”
BackgroundLecours, C., Bordeleau, M., Cantin, L., Parent, M., Paolo, T. D., & Tremblay, M.-È. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00282 · Cited by 144
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
Jan, A., Gonçalves, N. P., Vægter, C. B., Jensen, P. H., & Ferreira, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158338 · Cited by 144
Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation
Marreiros, R., Müller-Schiffmann, A., Trossbach, S. V., Prikulis, I., Hänsch, S., Weidtkamp-Peters, S., Moreira, A. R., Sahu, S., Soloviev, I., Selvarajah, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906466117 · Cited by 143 · cited 1×
“Those results clearly hint at a selective effect of H1N1 virus on α-syn misfolding [55].”
BackgroundExosomes in Parkinson’s Disease
Wu, X., Zheng, T., & Zhang, B. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0092-z · Cited by 143 · cited 1×
“Given the established role of exosomes both in pathophysiological neuronal processes, and PD development and progression [294,295], as well as their emerging significance in SARS-CoV-2 infection and propagation [285], we believe that cascading from SARS-CoV-2 infection to post-COVID-19 parkinsonism and, possibly PD on…”
BackgroundMalkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-24 · Cited by 142
Khorramdelazad, H., Kazemi, M. H., Najafi, A., Keykhaee, M., Emameh, R. Z., & Falak, R. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104554 · Cited by 142 · cited 1×
“Thus, since SARS-CoV-2 shares immunopathological similarities with other viruses linked to parkinsonism, such as influenza [75], and because of COVID-19-related neurological consequences, it is reasonable to suspect that these persistent symptoms might be a prologue to a post-COVID-19 new-onset neurological disease.”
BackgroundAutophagy impairment in Parkinson’s disease
Karabiyik, C., Lee, M. J., & Rubinsztein, D. C. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170023 · Cited by 140 · cited 2×
“Impairment or even failure of these systems may contribute to PD pathogenesis and progression [21,206].”
BackgroundNfL as a biomarker for neurodegeneration and survival in Parkinson disease
Bäckström, D., Linder, J., Jakobson Mo, S., Riklund, K., Zetterberg, H., Blennow, K., Forsgren, L., & Lenfeldt, N. (2020) · Neurology · doi:10.1212/wnl.0000000000010084 · Cited by 137
Karimi-Moghadam, A., Charsouei, S., Bell, B., & Jabalameli, M. R. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0587-4 · Cited by 136 · cited 1×
“Although PD is generally an idiopathic disorder, there is 5–10% of PD cases that report a family history or display a clear Mendelian inheritance [9,10].”
BackgroundA new dopaminergic nigro-olfactory projection
Höglinger, G. U., Alvarez‐Fischer, D., Arias-Carrión, Ó., Djufri, M., Windolph, A., Keber, U., Borta, A., Ries, V., Schwarting, R. K. W., Scheller, D., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1451-y · Cited by 135
Is COVID-19 a Perfect Storm for Parkinson’s Disease?
Brundin, P., Nath, A., & Beckham, J. D. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.009 · Cited by 132
SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment
Shang, C., Liu, Z., Zhu, Y., Lu, J., Ge, C., Zhang, C., Li, N., Jin, N., Li, Y., Tian, M., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.780768 · Cited by 132 · cited 1×
“Furthermore, the virus prevents mitophagy by blocking the binding of p62 and microtubule-associated protein 1A/1B-light chain 3 (LC3), thereby hindering viral RNA breakdown [185].”
BackgroundInfectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications
Limphaibool, N., Iwanowski, P., Holstad, M. J. V., Kobylarek, D., & Kozubski, W. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00652 · Cited by 130 · cited 4×
“The key pathophysiological processes by which viruses contribute to parkinsonism development remain unclear; however, direct neuronal damage, sustained neuroinflammation, cerebral edema due to virus-mediated damage of brain endothelium, and induction of α-syn aggregation have all been proposed as crucial neurobiologic…”
BackgroundInfluentialWang, J., Chen, S., & Bihl, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4213541 · Cited by 128 · cited 1×
“Recent data revealed that EVs carry and transfer ACE2 between different types of cells [288].”
BackgroundPost-COVID 19 neurological syndrome: Implications for sequelae’s treatment
Camargo-Martínez, W., Lozada-Martínez, I. D., Escobar-Collazos, A., Navarro-Coronado, A., Moscote‐Salazar, L. R., Pacheco-Hernández, A., Janjua, T. M., & Bosque‐Varela, P. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.04.001 · Cited by 128
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“281 Previous studies have demonstrated an association between COVID-19 and long-term brain atrophy and cognitive impairment in older individuals.”
Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms
Granholm, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093190 · Cited by 41
“Exosomes constitute a reliable route for misfolded protein transmission, contributing to the pathogenesis of neurodegenerative conditions such as PD and AD [100].”
InfluentialControversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era
Surguchov, A. P., Emamzadeh, F. N., Titova, M., & Surguchev, A. A. (2023) · Biomedicines · doi:10.3390/biomedicines11041215 · Cited by 36
“An interesting hypothesis is that SARS-CoV-2 proteins are carried out as exosomal cargo together with host proteins, promoting neurodegenerative and neuroinflammatory cascades, leading to the development of synucleinopathies [86].”
BackgroundDual Role of Exosome in Neurodegenerative Diseases: A Review Study
Sheykhhasan, M., Heidari, F., Farsani, M. E., Azimzadeh, M., Kalhor, N., Ababzadeh, S., & Seyedebrahimi, R. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230726161035 · Cited by 32
Li, H., Qian, J., Wang, Y., Wang, J., Mi, X., Qu, L., Song, N., & Xie, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102288 · Cited by 23
Metadata
- Authors
- Mysiris, D. S., Vavougios, G. D., Karamichali, E., Papoutsopoulou, S., Stavrou, V. T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., Zarogiannis, S. G., Gourgoulianis, K., & Xiromerisiou, G.
- Affiliations
- University of Thessaly (GR)
- Pasteur Hellenic Institute (GR)
- 1st Neurology Department, Eginition Hospital, Medical School, National & Kapodistrian University of Athens, 11528 Athens, Greece
- Corresponding author
- Xiromerisiou, Georgia
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-08-28
- Volume
- 23
- Issue
- 17
- Pages
- 9739
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9456372
- OpenAlex
- W4293536938
- Cited by
- 25
- References
- 335
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 9
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- Parkinson's disease pathogenesis, exosomes, exosomal cargo, SARS-CoV-2, alpha-synuclein aggregation, dopaminergic neuron loss, neuroinflammation, neurodegeneration, extracellular vesicles
- MeSH terms
- COVID-19, SARS-CoV-2, Cell Communication, Humans, Parkinson Disease, RNA, Viral, Neurodegenerative Diseases, Parkinsonian Disorders, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.